Plasma exchange; a promising treatment for toxic epidermal necrolysis with AIDS [4]

AIDS

Volumn 18, Issue 18, 2004, Pages 2446-2448

  Nomura, Toshifumi ^a   Abe, Riichiro ^a   Fujimoto, Katsuya ^a   Endo, Tomoyuki ^a   Shimizu, Hiroshi ^a   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHYLPREDNISOLONE; RIFABUTIN; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG WITHDRAWAL; HUMAN; LETTER; MILIARY TUBERCULOSIS; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; DRUG COMBINATIONS; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; MALE; PLASMA EXCHANGE; PNEUMONIA, PNEUMOCYSTIS; SULFAMETHIZOLE; TRIMETHOPRIM; TUBERCULOSIS, MILIARY; TUBERCULOSIS, UROGENITAL;

EID: 11244299905     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Cooperman SA. Cutaneous drug reactions in human immunodeficiency virus infection. Arch Dermatol 1991; 127:714-717.
2. Revuz J, Penso D, Roujeau JC, Guillaume JC, Rayne CR, Wechsler J, Touraine R. Toxic epidermal necrolysis: clinical findings and prognostic factors in 87 patients. Arch Dermatol 1987; 123:1160-1165.
3. Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992; 26:567-574.
4. Sherertz EF, Jegasothy BV, Lazarus GS. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy". J Am Acad Dermatol 1985; 12:178-181.
5. Roujeau IC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23:1039-1058.
6. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282:490-493.
7. Bamichas G, Natse T, Christidou F, Stangou M, Karagianni A, Koukourikos S, et al. Plasma exchange in patients with toxic epidermal necrolysis. Ther Apher 2002; 6:225-228.
8. Renfro L, Grant-Kels JM, Darman LA. Drug induced toxic epidermal necrolysis treated with cyclosporine. Int J Dermatol 1989; 28:441-444.
9. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003; 162:1515-1520.
10. Sanwo M, Nwadiuko R, Beall G. Use of intravenous immunoglobulin in the treatment of severe cutaneous reactions in patients with AIDS. J Allergy Clin Immunol 1996; 98:1112-1115.
11. Phan TG, Wong RC, Crotty K, Adelstein S. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin. Australas J Dermatol 1999; 40: 153-157.
12. Tan A, Tan HH, Lee CC, Ng SK. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins. Clin Exp Dermatol 2003; 28:269-271.
13. Ahsan N, Wiegand LA, Abendroth CS, Manning EC. Acute renal failure following immunoglobulin therapy. Am J Nephrol 1996; 16:532-536.